--- title: "ADARx Pharmaceuticals (ADRX) news: IPO and offering" url: "https://aibio.space/companies/adarx-pharmaceuticals/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ADRX IPO and offering news: ADARx Pharmaceuticals closes IPO of 26,250,000 shares at $17.00 each. ADARx Pharmaceuticals, Inc. (NASDAQ: ADRX), United States." --- ADRX ADARx Pharmaceuticals, Inc. NASDAQ · United States # ADARx Pharmaceuticals (ADRX) news ADRX IPO and offering news Financings · 2026-09-28 ## [ADARx Pharmaceuticals closes IPO of 26,250,000 shares at $17.00 each](https://aibio.space/news/adarx-pharmaceuticals-closes-ipo-26-250-000-shares-17-00-each/) ADARx Pharmaceuticals sold 26,250,000 shares at $17.00 in its IPO for about $446.3 million gross, and AbbVie bought 5,255,542 shares in a concurrent private placement worth about $89.3 million. The company had net losses of $46.4 million in 2024 and $73.1 million in 2025. ## Latest ADARx Pharmaceuticals news 1. 2026-09-04 Financings [ADARx Pharmaceuticals files for IPO, plans Nasdaq listing as ADRX](https://aibio.space/news/adarx-pharmaceuticals-files-ipo-plans-nasdaq-listing-adrx/) ADARx Pharmaceuticals filed an S-1 for a Nasdaq IPO under ADRX, with five banks on the cover and the share count and price range left blank. Its net loss was $73,088 thousand in 2025, and it holds a $335.0 million upfront payment from AbbVie. ## ADARx Pharmaceuticals at a glance - **Ticker**: ADRX - **Listing**: NASDAQ - **Country**: United States ### Related companies - [ALX Oncology Holdings](https://aibio.space/companies/alx-oncology/) NASDAQ: ALXO - [Senti Biosciences Holdings](https://aibio.space/companies/senti-biosciences/) NASDAQ: SNTI - [CERo Therapeutics Holdings](https://aibio.space/companies/cero-therapeutics/) OTC: CERO - [60 Degrees Pharmaceuticals](https://aibio.space/companies/60-degrees-pharmaceuticals/) NASDAQ: SXTP - [Alector](https://aibio.space/companies/alector/) NASDAQ: ALEC - [Pliant Therapeutics](https://aibio.space/companies/pliant-therapeutics/) NASDAQ: PLRX - [Rallybio](https://aibio.space/companies/rallybio/) NASDAQ: RLYB - [Manhattan Scientifics](https://aibio.space/companies/manhattan-scientifics/) OTC: MHTX ### Also on NASDAQ - [Retension Pharmaceuticals](https://aibio.space/companies/retension-pharmaceuticals/) RTSN - [UFP TECHNOLOGIES INC](https://aibio.space/companies/ufp-technologies/) UFPT - [Atea Pharmaceuticals](https://aibio.space/companies/atea-pharmaceuticals/) AVIR - [BridgeBio Pharma](https://aibio.space/companies/bridgebio-pharma/) BBIO - [CapsoVision](https://aibio.space/companies/capsovision/) CV - [Shattuck Labs](https://aibio.space/companies/shattuck-labs/) STTK ## Questions about ADARx Pharmaceuticals When did ADARx Pharmaceuticals go public? Our latest story on this, dated Sep 28, 2026: "ADARx Pharmaceuticals closes IPO of 26,250,000 shares at $17.00 each". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/adarx-pharmaceuticals-closes-ipo-26-250-000-shares-17-00-each/). Has ADARx Pharmaceuticals raised money recently? Our latest story on this, dated Sep 28, 2026: "ADARx Pharmaceuticals closes IPO of 26,250,000 shares at $17.00 each". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/adarx-pharmaceuticals-closes-ipo-26-250-000-shares-17-00-each/). What is the ticker symbol of ADARx Pharmaceuticals? ADARx Pharmaceuticals, Inc. trades under the ticker ADRX on NASDAQ. Where is ADARx Pharmaceuticals listed? ADARx Pharmaceuticals, Inc. is listed on NASDAQ. What is the SEC CIK of ADARx Pharmaceuticals? The SEC Central Index Key (CIK) for ADARx Pharmaceuticals, Inc. is 1802369. Its filings are on SEC EDGAR. Which country or territory is ADARx Pharmaceuticals listed under? Our directory records ADARx Pharmaceuticals, Inc. under United States. What does ADARx Pharmaceuticals do? Our directory classifies ADARx Pharmaceuticals, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of ADARx Pharmaceuticals? The ISIN recorded for ADARx Pharmaceuticals, Inc. is US00654F1057. Does aibio.space cover ADARx Pharmaceuticals? aibio.space lists ADARx Pharmaceuticals, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is ADARx Pharmaceuticals incorporated? SEC records list its state or country of incorporation as DE. What is the latest ADARx Pharmaceuticals (ADRX) stock news? Our latest story on ADARx Pharmaceuticals, dated Sep 28, 2026: "ADARx Pharmaceuticals closes IPO of 26,250,000 shares at $17.00 each". ADARx Pharmaceuticals sold 26,250,000 shares at $17.00 in its IPO for about $446.3 million gross, and AbbVie bought 5,255,542 shares in a concurrent private placement worth about $89.3 million. The company had net losses of $46.4 million in 2024 and $73.1 million in 2025. [Source](https://aibio.space/news/adarx-pharmaceuticals-closes-ipo-26-250-000-shares-17-00-each/). Is ADARx Pharmaceuticals a smaller reporting company? SEC records list ADARx Pharmaceuticals, Inc.'s filer category as:
Emerging growth company. Where is ADARx Pharmaceuticals headquartered? SEC records list its business address as 5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121. When does ADARx Pharmaceuticals's fiscal year end? ADARx Pharmaceuticals, Inc.'s fiscal year ends on December 31, per SEC records. What did ADARx Pharmaceuticals last file with the SEC? Its most recent filing in our record is an 8-K filed 2026-09-28. All of its filings are on SEC EDGAR. [Source](https://www.sec.gov/Archives/edgar/data/1802369/000119312526405297/d186630d8k.htm). ## Investor discussion: ADARx Pharmaceuticals Members talk about ADARx Pharmaceuticals (ADRX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at ADARx Pharmaceuticals, newest first. Each line links the filing it comes from. 1. 2026-09-28 Financings Reported an unregistered sale of its securities. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1802369/000119312526403094/d903461d424b4.htm) 2. 2026-09-04 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1802369/000119312526383838/d903461ds1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ADRX on TradingView](https://www.tradingview.com/symbols/NASDAQ-ADRX/). ## SEC filings and registration - **SEC name**: ADARx Pharmaceuticals, Inc. - **CIK**: 1802369 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: ADRX (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121 - **Phone**: 858-283-9472 ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1802369/000119312526405297/d186630d8k.htm) filed 2026-09-28 - [S-1](https://www.sec.gov/Archives/edgar/data/1802369/000119312526383838/d903461ds1.htm) filed 2026-09-04 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001802369), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details ADARx Pharmaceuticals, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ADRX, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ADARx Pharmaceuticals, Inc. - **Ticker**: ADRX - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US00654F1057 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-ADRX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/adarx-pharmaceuticals/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ADARx Pharmaceuticals (ADRX) news: IPO and offering", 2026-10-31, https://aibio.space/companies/adarx-pharmaceuticals/